VOR Stock Price | Vor Biopharma Inc P/E, Revenue, EPS, & Forecasts

Vor Biopharma Inc • VOR

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Vor Biopharma Inc

Ticker

VOR

Trading on

NASDAQ

ISIN

US9290331084

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Jean-Paul Kress M.D.

Headquarters

500 Boylston Street, Boston, MA, United States, 02116

Employees

Website

vorbio.com

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Metrics

BasicAdvanced

Market cap

$785M

P/E ratio

EPS

-$70.40

Dividend Yield

0.00%

Beta

1.73

Forward P/E ratio

EBIDTA

$-342M

Ex dividend date

Price & volume

Market cap

$785M

Average daily volume

1.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

0.66

Earnings

EPS

-$70.40

EPS estimate (current quarter)

-$0.78

EPS estimate (next quarter)

-$0.84

EBITDA

$-342M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.73

52-week High

$65.80

52-week Low

$6.50

50-day moving average

$14.78

200-day moving average

$17.55

Short ratio

5.86

Short %

10.64%

Management effectiveness

ROE (TTM)

-125.43%

ROA (TTM)

-69.76%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

54.2M

Float

40.2M

Insiders %

4.27%

Institutions %

69.40%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 5 analysts.

Average price target

$37.88

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$251.24

-$0.22

-111,910.70%

Q2 • 25Missed

-$121.60

-$0.10

-121,500.00%

Q3 • 25Missed

$307.53

-$1.19

25,921.16%

Q4 • 25Beat

-$0.73

-$0.78

7.22%

Q1 • 26Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$1.72B

∞%

Q4 • 25

$0M

$-220M

-∞%

Q1 • 26

NaN%

-112.75%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$464M

$628M

135.40%

Q4 • 25

$507M

$657M

129.68%

Q1 • 26

9.18%

4.57%

-4.22%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-22.8M

$-48.7M

$308M

$-23.1M

Q4 • 25

$-38.2M

$-263M

$74.9M

$-38.3M

Q1 • 26

67.74%

440.87%

-75.68%

65.67%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Vor Biopharma Inc share?

Vor Biopharma Inc shares are currently traded for undefined per share.

How many shares does Vor Biopharma Inc have?

Vor Biopharma Inc currently has 54.2M shares.

Does Vor Biopharma Inc pay dividends?

No, Vor Biopharma Inc doesn't pay dividends.

What is Vor Biopharma Inc 52 week high?

Vor Biopharma Inc 52 week high is $65.80.

What is Vor Biopharma Inc 52 week low?

Vor Biopharma Inc 52 week low is $6.50.

What is the 200-day moving average of Vor Biopharma Inc?

Vor Biopharma Inc 200-day moving average is $17.55.

Who is Vor Biopharma Inc CEO?

The CEO of Vor Biopharma Inc is Dr. Jean-Paul Kress M.D..

How many employees Vor Biopharma Inc has?

Vor Biopharma Inc has 76 employees.

What is the market cap of Vor Biopharma Inc?

The market cap of Vor Biopharma Inc is $785M.

What is the P/E of Vor Biopharma Inc?

The current P/E of Vor Biopharma Inc is null.

What is the EPS of Vor Biopharma Inc?

The EPS of Vor Biopharma Inc is -$70.40.

What is the PEG Ratio of Vor Biopharma Inc?

The PEG Ratio of Vor Biopharma Inc is null.

What do analysts say about Vor Biopharma Inc?

According to the analysts Vor Biopharma Inc is considered a hold.